Redhill Biopharma Ltd (RDHL) Live Share Price, Invest From India

Redhill Biopharma Ltd Stock Performance

as on May 6, 2026 at 6:57 am IST

Day's Low
Day's High
$0.93
Day's Price Range
$1.04
$1.01
7.92%
Downside
2.97%
Upside
52 Week's Low
52 Week's High
$0.71
52-Week Price Range
$3.31
$1.01
29.69%
Downside
227.71%
Upside

Redhill Biopharma Ltd share price movements today

Previous Close: $1.04
Open: $1.02
Volume: 3.8M
Day's Low - High: $0.93 - $1.04
52 Week Low - High: $0.71 - $3.31

Redhill Biopharma Ltd Historical Returns

1 Month Return: + 23.02 %
3 Month Return: -4.67 %
1 Year Return: -47.15 %
3 Year Return: -98.1 %
5 Year Return: -99.98 %

Redhill Biopharma Ltd Stock Fundamentals & Key Indicators

Check Redhill Biopharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.5M

Revenue (TTM)

286.0K

Profit Margin

-150.00%

Return On Equity TTM

-1708.61%

Redhill Biopharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Redhill Biopharma Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Redhill Biopharma Ltd	BUY	$5.4M	-99.98%	NA	-150.00%
United Therapeutics Corporation	BUY	$24.3B	NA	20.54	41.94%
Viatris Inc	HOLD	$17.7B	11.41%	NA	-24.58%
Haleon plc	BUY	$40.7B	NA	18.34	15.11%
Zoetis Inc	BUY	$47.5B	-32.82%	18.69	28.24%

Stock Returns calculator for Redhill Biopharma Ltd Stock including INR - Dollar returns

The Redhill Biopharma Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Redhill Biopharma Ltd investment value today

Current value as on today

₹58,736

Returns

-₹41,264

(-41.26%)

Returns from Redhill Biopharma Ltd Stock

-₹47,668 (-47.67%)

Dollar Impact

₹6,404 (+6.4%)

Analyst Recommendation on Redhill Biopharma Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Redhill Biopharma Ltd. Average target price of $19000

Redhill Biopharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Redhill Biopharma Ltd.

What analysts predicted

99.99%UPSIDE

Target Price

$19000

Current Price

$1.01

Analyzed by

7 Analysts

Target

$19000.00

Redhill Biopharma Ltd target price $19000, a slight upside of 99.99% compared to current price of $1.01. According to 7 analysts rating.

Redhill Biopharma Ltd Stock’s Investor Sentiment and Interest

Search interest for Redhill Biopharma Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:47% versus previous 30 day period

Redhill Biopharma Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	17	12	12	1	0	1	1	2	2	2
Gross Profit	8	4	4	0	0	0	0	1	1	1
Operating Income	-7	-9	-9	-4	-6	-4	-4	-3	-2	-2
EBITDA	-1	0	0	2	-5	-4	-4	-1	-2	-2
Interest Expense	31	1	1	1	-	0	0	-	0	0
Depreciation	2	2	60	-58	-	-	-	-	-	-
Income Before Tax	-35	-3	-3	0	-13	-1	-1	-2	-2	-2
Income Tax Expense	28	-6	-6	0	-	-	-	-	-	-
Net Income	-35	2	-3	0	-13	-1	-1	-2	-2	-2
Net Profit Margin	-203.40%	19.46%	-29.14%	42.37%	-2386.43%	-120.06%	-120.06%	-94.68%	-101.32%	-101.32%

Redhill Biopharma Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	4	8	6	64	85	61	6	8	0
Gross Profit	-30	1	5	4	27	36	28	3	4	0
Operating Income	-30	-51	-39	-43	-63	-81	-42	12	-14	-7
EBITDA	-30	-45	-38	-40	-54	-63	-22	26	-7	-7
Interest Expense	0	0	0	0	12	16	41	0	0	0
Depreciation	-	0	0	1	8	18	8	1	0	0
Income Before Tax	-29	-45	-38	-42	-76	-97	-71	23	-8	-8
Income Tax Expense	1	6	0	1	12	16	-12	0	-	-
Net Income	-29	-45	-38	-42	-76	-97	-71	23	-8	0
Net Profit Margin	-29079.21%	-1136.61%	-464.35%	-672.45%	-118.36%	-113.98%	-115.97%	366.25%	-102.80%	-150.00%

Redhill Biopharma Ltd Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Net Income	-3	0	-13	-13	-1	-1	-2	-2	-2
Operating Cash Flow	-2	-10	-9	-	-3	-3	-1	-2	-2
Investing Cash Flow	-8	0	0	-	0	0	0	0	0
Financing Cash Flow	7	0	8	-	3	3	0	1	1
Change in Cash	4	-10	-6	-	-	7	-7	-	-

Redhill Biopharma Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-45	-38	-42	-76	-97	-71	23	-8	0
Operating Cash Flow	-44	-34	-40	-48	-65	-29	-35	-9	-9
Investing Cash Flow	-18	5	5	-35	-8	8	0	0	1
Financing Cash Flow	25	41	35	84	73	11	21	8	7
Change in Cash	-37	12	0	0	0	-9	-14	0	0

Global Institutional Holdings in Redhill Biopharma Ltd

Funds	Holdings
Advisor Group Holdings, Inc.	0%
Bank of America Corp	0.01%
Citadel Advisors Llc	0.3%
Federation des caisses Desjardins du Quebec	0.07%
Your Advocates Ltd., LLP	0%

See all

Insights on Redhill Biopharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -2.59M → -2.06M (in $), with an average increase of 12.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 94.0% return, outperforming this stock by 141.2%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 167.2% return, outperforming this stock by 265.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, RDHL stock has moved down by -98.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.73M → 2.03M (in $), with an average decrease of 12.7% per quarter

About Redhill Biopharma Ltd

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv-Yafo, Israel.

Organisation	Redhill Biopharma Ltd
Headquarters	21 Ha?arba?a Street, Tel Aviv-Yafo, Israel, 6473921
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Dror Ben-Asher
E-voting on shares	Click here to vote

Key Management of Redhill Biopharma Ltd

Name	Title
Mr. Dror Ben-Asher	Co-Founder, Chairman & CEO
Mr. Razi Ingber	Chief Financial Officer
Mr. Gilead Raday MPhil, MSc	Chief Operating Officer
Dr. Reza Fathi Ph.D.	Senior Vice President of Research & Development
Mr. Guy Goldberg J.D.	Chief Business Officer
Ms. Patricia Anderson B.Sc. RAC	Senior Vice President of Regulatory Affairs
Mr. Adi Frish	Chief Corporate & Business Development Officer
Mr. Rick D. Scruggs	Chief Commercial Officer & Director
Dr. Mark L. Levitt M.D., Ph.D.	Chief Scientific Officer
Ms. Alexandra Okmian	Senior Business Development & Investor Relations Manager

FAQs

What is Redhill Biopharma Ltd share price today?

Redhill Biopharma Ltd share price today is $1.01 as on May 6, 2026 at 1:27 am IST at the close of the market. Redhill Biopharma Ltd share today touched a day high of $1.04 and a low of $0.93.

What is the 52 week high and 52 week low for Redhill Biopharma Ltd share?

Redhill Biopharma Ltd share touched a 52 week high of $3.31 on July 21, 2025 and a 52 week low of $0.71 on March 30, 2026. Redhill Biopharma Ltd stock price today i.e. May 6, 2026 at 1:27 am IST is closed at $1.01,which is 69.49% down from its 52 week high and 42.23% up from its 52 week low.

What is Redhill Biopharma Ltd's market capitalisation today?

Redhill Biopharma Ltd market capitalisation is $0.00T as on May 6, 2026 at 1:27 am IST.

How to invest in Redhill Biopharma Ltd Stock (RDHL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Redhill Biopharma Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Redhill Biopharma Ltd Shares that will get you 1.4851 shares as per Redhill Biopharma Ltd share price of $1.01 per share as on May 6, 2026 at 1:27 am IST.

What is the minimum amount required to buy Redhill Biopharma Ltd Stock (RDHL) from India?

Indian investors can start investing in Redhill Biopharma Ltd (RDHL) shares with as little as ₹94.61 or $1 (as of May 6, 2026 at 4:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Redhill Biopharma Ltd stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 4:44 pm IST). Based on Redhill Biopharma Ltd share’s latest price of $1.01 as on May 6, 2026 at 1:27 am IST, you will get 9.9010 shares of Redhill Biopharma Ltd. Learn more about fractional shares .

What are the returns that Redhill Biopharma Ltd has given to Indian investors in the last 5 years?

Redhill Biopharma Ltd stock has given -99.98% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?